Morgan Stanley’s Innophos Holdings, Inc. IPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-103,683
Closed -$3.32M 6901
2019
Q4
$3.32M Buy
103,683
+32,472
+46% +$1.04M ﹤0.01% 3621
2019
Q3
$2.31M Sell
71,211
-21,167
-23% -$610K ﹤0.01% 3638
2019
Q2
$2.69M Sell
92,378
-16,248
-15% -$486K ﹤0.01% 3531
2019
Q1
$3.27M Buy
108,626
+70,611
+186% +$2.12M ﹤0.01% 3124
2018
Q4
$932K Sell
38,015
-63,170
-62% -$1.92M ﹤0.01% 4326
2018
Q3
$4.49M Buy
101,185
+24,241
+32% +$1.11M ﹤0.01% 3298
2018
Q2
$3.66M Buy
76,944
+22,141
+40% +$1.01M ﹤0.01% 3516
2018
Q1
$2.2M Sell
54,803
-44,033
-45% -$1.93M ﹤0.01% 3914
2017
Q4
$4.62M Sell
98,836
-83,611
-46% -$3.91M ﹤0.01% 3194
2017
Q3
$8.97M Buy
182,447
+3,715
+2% +$167K ﹤0.01% 2391
2017
Q2
$7.84M Buy
178,732
+6,309
+4% +$283K ﹤0.01% 2409
2017
Q1
$9.31M Buy
172,423
+24,858
+17% +$1.28M ﹤0.01% 2269
2016
Q4
$7.71M Buy
147,565
+22,257
+18% +$1.08M ﹤0.01% 2537
2016
Q3
$4.89M Buy
125,308
+44,183
+54% +$1.82M ﹤0.01% 2673
2016
Q2
$3.42M Buy
81,125
+4,013
+5% +$151K ﹤0.01% 2950
2016
Q1
$2.38M Sell
77,112
-77,423
-50% -$2.13M ﹤0.01% 3204
2015
Q4
$4.48M Buy
154,535
+14,205
+10% +$500K ﹤0.01% 2767
2015
Q3
$5.56M Buy
140,330
+98,074
+232% +$4.75M ﹤0.01% 2557
2015
Q2
$2.23M Sell
42,256
-30,149
-42% -$1.64M ﹤0.01% 3533
2015
Q1
$4.08M Sell
72,405
-28,715
-28% -$1.68M ﹤0.01% 2947
2014
Q4
$5.91M Buy
101,120
+9,973
+11% +$560K ﹤0.01% 2564
2014
Q3
$5.02M Buy
91,147
+46,245
+103% +$2.68M ﹤0.01% 2634
2014
Q2
$2.58M Buy
44,902
+20,810
+86% +$1.13M ﹤0.01% 3281
2014
Q1
$1.37M Buy
24,092
+3,489
+17% +$179K ﹤0.01% 3746
2013
Q4
$1M Sell
20,603
-1,678
-8% -$83.7K ﹤0.01% 3937
2013
Q3
$1.18M Sell
22,281
-7,828
-26% -$395K ﹤0.01% 3658
2013
Q2
$1.42M Buy
+30,109
New +$1.56M ﹤0.01% 3415

Other funds holding IPHS

Morgan Stanley's IPHS Position: Q1 2020 in Review

Morgan Stanley sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 103,683 shares — an estimated $3.32M sold.

Morgan Stanley first reported a position in IPHS in Q2 2013 and held it in 27 quarters. The position peaked at $9.31M in Q1 2017. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

  • Morgan Stanley reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
  • Morgan Stanley sold 103,683 Innophos Holdings, Inc. shares in Q1 2020, an estimated $3.32M.
  • Morgan Stanley first reported a position in Innophos Holdings, Inc. in Q2 2013 and held it in 27 quarters.
  • Morgan Stanley's Innophos Holdings, Inc. position peaked at $9.31M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Morgan Stanley's 13F filing for Q1 2020, filed 15 May 2020.